Amarin Corp Plc (AMRN)

[ziploc_1]

The eventual solution to Amarin's problems is to regain the U.S. market for Vascepa...The settlement of the Healthnet case apparently is not going to do it....The patented gel capsule is not going to do it...An AG is apparently not going to do it...This leaves an FTC, preferably with MND-2119(with a re-instatement of reps and advertising) as the probable solution to Amarn's problem.

To undertake this strategy Amarin needs a well funded initiative by a cash rich BP.